Age Labs is a Norwegian molecular diagnostics company that discovers, develops and commercializes diagnostic tests for the early detection of age-related diseases. Our pipeline includes a biological age predictor and a test predicting the severity of COVID-19 infection. Our service includes evaluating epigenetic drug effects for use in clinical trials.
Age Labs offers comprehensive reports on epigenetic drug effects for use in clinical trials.
Our main customers are companies from the pharmaceutical and nutraceutical industry.
By using advanced machine learning on epigenetic datasets from biobanks, we develop biomarkers for the early detection of diseases.
We have several R&D projects in collaboration with public institutions in Norway.